Dapagliflozin in Patients With Atrial Fibrillation (DAPA-AF)
Abroad (travel likely)RecruitingPHASE3
Conditions
Diabetes Mellitus · Atrial Fibrillation
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States
Contact: Principal Investigator (Zain Asad, MD)
Study leads
Zain Ul Abideen Asad, MD
Principal Investigator
University of Oklahoma